What is ePatientFinder?
Elligo Health Research serves as a critical intermediary in the pharmaceutical and biotechnology landscape, providing comprehensive clinical trial management solutions. The company leverages its IntElligo Research Stack to optimize site support services and streamline patient recruitment, which remains a primary bottleneck in drug development. By integrating healthcare-first and research-only sites into a unified marketplace, Elligo enhances the efficiency of study execution. Their market position is defined by a focus on operational excellence, enabling sponsors to accelerate research timelines while maintaining high standards of patient engagement and data integrity across more than 1,000 active studies.
How much funding has ePatientFinder raised?
ePatientFinder has raised a total of $13.4M across 3 funding rounds:
Series A
$2.6M
Series B
$8.2M
Debt
$2.6M
Series A (2015): $2.6M, investors not publicly disclosed
Series B (2016): $8.2M, investors not publicly disclosed
Debt (2017): $2.6M, investors not publicly disclosed
Key Investors in ePatientFinder
Undisclosed Institutional Partner
An institutional investment firm focused on scaling healthcare technology platforms through strategic capital allocation.
Undisclosed Venture Capital Firm
A venture capital entity specializing in early-to-growth stage life sciences and digital health innovation.
Undisclosed Debt Financing Provider
A financial institution providing structured debt solutions to support operational expansion and infrastructure development.
What's next for ePatientFinder?
Looking ahead, the strategic deployment of the $2.6M capital is expected to focus on the further integration of advanced data analytics and the expansion of the company's global site network. As the clinical research industry faces increasing pressure to reduce time-to-market for novel therapies, Elligo is well-positioned to capitalize on the demand for decentralized and technology-enabled trial models. Future growth will likely center on enhancing the interoperability of their research stack, ensuring that sponsors can access real-time insights into patient eligibility and site performance. This focus on technological scalability will be instrumental in maintaining their competitive advantage as they continue to facilitate complex, multi-country clinical trials.
See full ePatientFinder company page
